Norway Small Molecule Cdmo Market Size & Outlook
Norway small molecule cdmo market, 2018-2030 (US$M)
Related Markets
Norway small molecule cdmo market highlights
- The Norway small molecule cdmo market generated a revenue of USD 673.8 million in 2023 and is expected to reach USD 1,063.3 million by 2030.
- The Norway market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
- In terms of segment, active pharmaceutical ingredients (api) was the largest revenue generating product in 2023.
- Active Pharmaceutical Ingredients (API) is the most lucrative product segment registering the fastest growth during the forecast period.
Small molecule cdmo market data book summary
| Market revenue in 2023 | USD 673.8 million |
| Market revenue in 2030 | USD 1,063.3 million |
| Growth rate | 6.7% (CAGR from 2023 to 2030) |
| Largest segment | Active pharmaceutical ingredients (api) |
| Fastest growing segment | Active Pharmaceutical Ingredients (API) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Active Pharmaceutical Ingredients (API), Finished Drug Products |
| Key market players worldwide | Lonza Group Ltd, Catalent Inc, Thermo Fisher Scientific Inc, Siegfried Holding AG, Eurofins Scientific SE, Aurigene Pharmaceutical Services |
Other key industry trends
- In terms of revenue, Norway accounted for 1.0% of the global small molecule cdmo market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK small molecule cdmo market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 4,748.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Small Molecule CDMO Market Scope
Small Molecule CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway small molecule cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to small molecule cdmo market will help companies and investors design strategic landscapes.
Active pharmaceutical ingredients (api) was the largest segment with a revenue share of 62.15% in 2024. Horizon Databook has segmented the Norway small molecule cdmo market based on active pharmaceutical ingredients (api), finished drug products covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Norway small molecule cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway small molecule cdmo market databook
-
Our clientele includes a mix of small molecule cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway small molecule cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Norway small molecule cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway small molecule cdmo market report size, by product, 2018-2030 (US$M)
Norway Small Molecule CDMO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
